Insider Buying Signals Confidence Amid Declining Stock: Unlocking CGuard’s Healthcare Value
Insider buying shows renewed confidence amid a 55% yearly loss; this article explains how leadership’s stake in the company could boost CGuard’s FDA, reimbursement, and tech‑delivery strategy to win value‑based care contracts and investor confidence.
5 minutes to read